Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Actinium Pharmaceuticals Inc (NYSE MKT LLC:ATNM)

1.64
BATS BZX Real-Time Price
As of 3:55pm ET
 -0.62 / -27.43%
Today’s Change
1.52
Today|||52-Week Range
8.12
-72.16%
Year-to-Date
No recent news for Actinium Pharmaceuticals Inc.

Today’s Trading

Previous close2.26
Today’s open2.20
Day’s range1.52 - 2.20
Volume2,148,038
Average volume (3 months)1,219,359
Market cap$87.0M
Dividend yield--
Data as of 3:40pm ET, 08/03/2015

Growth & Valuation

Earnings growth (last year)-91.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATHXAthersys Inc+0.01+0.95%
BLRXBioLine RX Ltd-0.03-1.58%
XOMAXOMA Corp+0.04+5.02%
NNVCNanoViricides Inc-0.06-4.00%
Data as of 3:55pm ET, 08/03/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$24.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO, Secretary &
Director
Kaushik J. Dave
Chief Operating &
Medical Officer
Dragan Cicic
Corporate headquarters
New York, New York

Forecasts